Greenrise Global Brands Inc. (C:XCX)
Business Focus: Alternative Medicine
Aug 08, 2022 03:00 am ET
Greenrise Announces Record Sales for Q2 and Comments on Positive Developments regarding the Legislation of Adult-Use Cannabis in Germany
VANCOUVER, BC and HAMBURG, Germany, Aug. 8, 2022 /CNW/ - Greenrise Global Brands Inc. (Frankfurt: C4T) (ISIN: CA39540L1085) (CSE: XCX) ("Greenrise" and "the Company") is pleased to provide preliminary, unaudited second quarter financial results for the three months ending June 30, 2022 ("Q2") and commentary on recent developments in the adult use of cannabis legislation in Germany.
Jun 20, 2022 03:00 am ET
Greenrise Provides Update on CannaCare's Sales Growth and First Quarter Results
HAMBURG, GERMANY, June 20, 2022 /CNW/ - Greenrise Global Brands Inc. (Frankfurt: C4T) (ISIN: CA39540L1085) (CSE: XCX) ("Greenrise"), which operates in the German CBD wellbeing and medical cannabis market announces its results for the three months ending March 31st, 2022 (Q1, 2022) and provides an update about the acquisition of CannaCare Health GmbH ("CannaCare").
May 11, 2022 03:05 am ET
Greenrise Announces Appointment of Frank Otto to the Board of Directors and Closing of the Acquisition of Control of CannaCare Health GmbH
HAMBURG, Germany, May 11, 2022 /CNW/ - Greenrise Global Brands Inc. (Frankfurt: C4T) (ISIN: CA39540L1085) (CSE: XCX) ("Greenrise''), which serves the medical and CBD cannabis market in Germany and CannaCare Health GmbH ("CannaCare"), owner of CANOBO, one of Germany's leading CBD brands announces the appointment of Mr. Frank Otto to the board of directors of Greenrise and the closing of the acquisition of 51% of CannaCare Health GmbH ("CannaCare") previously announced on April 5th, 2022. Greenrise has the exclusive option to purchase 49% of CannaCare for two years after closing for common sha
Apr 05, 2022 09:35 am ET
/R E P E A T -- Greenrise Advances its Leadership Position in Germany with the Acquisition of a Majority Interest in CannaCare Health GmbH and the Appointment of Frank Otto to its Board of Directors/
HAMBURG, Germany , April 5, 2022 /CNW/ - Greenrise Global Brands Inc. (Frankfurt: C4T) (ISIN: CA39540L1085) (CSE: XCX) ("Greenrise"), which serves the medical and CBD cannabis market in Germany, and CannaCare Health GmbH (CannaCare), owner of CANOBO, one of Germany's leading CBD brands announce that Greenrise has acquired a 51% interest in CannaCare from its co-founders Frank Otto and the Oplesch family (CannaCare Shareholders).
Apr 05, 2022 03:05 am ET
Greenrise Advances its Leadership Position in Germany with the Acquisition of a Majority Interest in CannaCare Health GmbH and the Appointment of Frank Otto to its Board of Directors
HAMBURG, Germany , April 5, 2022 /CNW/ - Greenrise Global Brands Inc. (Frankfurt: C4T) (ISIN: CA39540L1085) (CSE: XCX) ("Greenrise"), which serves the medical and CBD cannabis market in Germany, and CannaCare Health GmbH (CannaCare), owner of CANOBO, one of Germany's leading CBD brands announce that Greenrise has acquired a 51% interest in CannaCare from its co-founders Frank Otto and the Oplesch family (CannaCare Shareholders).
Jan 18, 2022 05:05 pm ET
Greenrise Global's Medical Cannabis Subsidiary, AMP Alternative Medical Products GmbH becomes Exclusive Distribution Partner of a Selection of Little Green Pharma Extracts in Germany
HAMBURG, Germany and PERTH, Australia, Jan. 18, 2022 /CNW/ - Greenrise Global Brands Inc. (Frankfurt: C4T, ISIN: CA39540L1085) (CSE: XCX) ("Greenrise Global") a distributor of medical and CBD wellness cannabis products in Germany announces that its wholly-owned subsidiary, AMP Alternative Medical Products GmbH ("AMP") and Little Green Pharma Ltd. (ASX: LGP) ("LGP"), a vertically integrated cannabis manufacturer, that AMP has been appointed as marketer and distributor of LGP medical cannabis extracts to pharmacies and clinics in Germany, including exclusive distributor of LGP's 20:5 LGP Class
Jan 12, 2022 02:05 am ET
Dec 22, 2021 08:00 am ET
Greenrise Global: Year-end Letter to the Shareholders
BERLIN, Dec. 22, 2021 /CNW/ - Greenrise Global Brands Inc. (Frankfurt: C4T) (ISIN: CA39540L1085) (CSE: XCX) ("Greenrise Global") is pleased to provide a year-end letter to its shareholders.
Dec 22, 2021 02:05 am ET
Greenrise Global: Year-end Letter to the Shareholders
BERLIN,, Dec. 22, 2021 /CNW/ - Greenrise Global Brands Inc. (Frankfurt: C4T) (ISIN: CA39540L1085) (CSE: XCX) ("Greenrise Global") is pleased to provide a year-end letter to its shareholders.
Nov 25, 2021 08:00 am ET
/R E P E A T -- Greenrise Global's Supports Germany's Approach to Cannabis Legalization for Adult Use/
BERLIN and ERFURT, Germany, Nov. 25, 2021 /CNW/ - Greenrise Global Brands Inc. (formerly AMP Alternative Medical Products Inc.) (Frankfurt: C4T) (ISIN: CA39540L1085) (CSE: XCX) ("Greenrise Global") would like to comment on the German coalition government's (SPD, Alliance 90/The Greens and FDP) announcement to legalize the sale of cannabis for consumption purposes to adults in licensed stores with the objective to control quality and ensure the protection of minors.
Nov 25, 2021 02:05 am ET
Greenrise Global's Supports Germany's Approach to Cannabis Legalization for Adult Use
BERLIN and ERFURT, Germany, Nov. 25, 2021 /CNW/ - Greenrise Global Brands Inc. (formerly AMP Alternative Medical Products Inc.) (Frankfurt: C4T) (ISIN: CA39540L1085) (CSE: XCX) ("Greenrise Global") would like to comment on the German coalition government's (SPD, Alliance 90/The Greens and FDP) announcement to legalize the sale of cannabis for consumption purposes to adults in licensed stores with the objective to control quality and ensure the protection of minors.
Nov 23, 2021 08:05 am ET
/R E P E A T -- Greenrise Global Launches Herbify CBD Wellness Brand in Germany/
BERLIN and HAMBURG, Germany, Nov. 23, 2021 /CNW/ - Greenrise Global Brands Inc.'s (formerly AMP Alternative Medical Products Inc.) (Frankfurt: C4T) (ISIN: CA39540L1085) (CSE: XCX), ("Greenrise Global"), announces the launch of its Herbify wellness brand of high-quality, cruelty-free and vegan CBD products designed to build on the power of the individual's daily self-care routine.
Nov 23, 2021 02:05 am ET
Greenrise Global Launches Herbify CBD Wellness Brand in Germany
BERLIN and HAMBURG, Germany, Nov. 23, 2021 /CNW/ - Greenrise Global Brands Inc.'s (formerly AMP Alternative Medical Products Inc.) (Frankfurt: C4T) (ISIN: CA39540L1085) (CSE: XCX), ("Greenrise Global"), announces the launch of its Herbify wellness brand of high-quality, cruelty-free and vegan CBD products designed to build on the power of the individual's daily self-care routine.
Nov 17, 2021 08:10 am ET
/R E P E A T -- Greenrise Global's Medical Cannabis Subsidiary Announces the Introduction of its Dronabinol Product to the German Market/
BERLIN and ERFURT, Germany, Nov. 17, 2021 /CNW/ - Greenrise Global Brands Inc.'s (formerly AMP Alternative Medical Products Inc.) (Frankfurt: C4T) (ISIN: CA39540L1085) (CSE: XCX), wholly-owned subsidiary, AMP Alternative Medical Products GmbH ("AMP"), a pharmaceutical supplier of medical cannabis products to German pharmacies, announces the launch of a new dronabinol medical cannabis product available in pharmacies beginning in January 2022.
Nov 17, 2021 02:05 am ET
Greenrise Global's Medical Cannabis Subsidiary Announces the Introduction of its Dronabinol Product to the German Market
BERLIN and ERFURT, Germany, Nov. 17, 2021 /CNW/ - Greenrise Global Brands Inc.'s (formerly AMP Alternative Medical Products Inc.) (Frankfurt: C4T) (ISIN: CA39540L1085) (CSE: XCX), wholly-owned subsidiary, AMP Alternative Medical Products GmbH ("AMP"), a pharmaceutical supplier of medical cannabis products to German pharmacies, announces the launch of a new dronabinol medical cannabis product available in pharmacies beginning in January 2022.
Nov 05, 2021 01:20 pm ET
CSE Bulletin: Name Change - AMP Alternative Medical Products Inc. (XCX)
Toronto, Ontario--(Newsfile Corp. - Le 5 novembre/November 2021) AMP Alternative Medical Products Inc. has announced a name change to Greenrise Global Brands Inc.
Nov 03, 2021 09:15 am ET
/R E P E A T -- AMP Announces Strategic Acquisition of German CBD Wellness Company and Leading Cannabis Executive Team/
BERLIN, Nov. 3, 2021 /CNW/ - AMP Alternative Medical Products Inc. (Frankfurt: C4TA) (ISIN: CA0318961038) (CSE: XCX), (the "Company") announces it has acquired Greenrise GmbH ("Greenrise Wellbeing") from its founders, Messrs. Hendrik Knopp, Florian Witt and Alex Hintz. Mr. Hendrik Knopp has been appointed to the board of directors, Mr. Florian Witt has been appointed as Chief Operating Officer and Mr. Alex Hintz as Chief Product Officer.
Nov 03, 2021 04:05 am ET
AMP Announces Strategic Acquisition of German CBD Wellness Company and Leading Cannabis Executive Team
BERLIN, Nov. 3, 2021 /CNW/ - AMP Alternative Medical Products Inc. (Frankfurt: C4TA) (ISIN: CA0318961038) (CSE: XCX), (the "Company") announces it has acquired Greenrise GmbH ("Greenrise Wellbeing") from its founders, Messrs. Hendrik Knopp, Florian Witt and Alex Hintz. Mr. Hendrik Knopp has been appointed to the board of directors, Mr. Florian Witt has been appointed as Chief Operating Officer and Mr. Alex Hintz as Chief Product Officer.
Sep 28, 2021 09:32 am ET
/R E P E A T -- AMP Becomes Exclusive Marketing Partner of Tilray for Aphria Medical Cannabis Brand in Germany/
ERFURT, Germany and BERLIN, Sept. 28, 2021 /CNW/ - AMP Alternative Medical Products Inc. (Frankfurt: C4TA, ISIN: CA0318961038) (CSE: XCX) ("AMP"), a pharmaceutical supplier of medical and CBD therapeutic wellness cannabis products to German pharmacies, announces it has been appointed as the sole marketing partner for all Aphria branded products imported or cultivated in Germany. Aphria is a medical cannabis brand of Tilray, Inc. (NASDAQ | TSX: TLRY) ("Tilray") a global pioneer in cannabis research, cultivation, production, and distribution.
Sep 28, 2021 03:05 am ET
Sep 13, 2021 09:00 am ET
/R E P E A T -- AMP Alternative Medical Products and Waldhausklinik Deuringen Announce Clinical Study into the Effects of Medical Cannabis/
ERFURT, Germany and BERLIN and STADTBERGEN, Germany, Sept. 13, 2021 /CNW/ - AMP Alternative Medical Products Inc. (Frankfurt: C4TA) (ISIN: CA0318961038) (CSE: XCX), a pharmaceutical supplier of medical cannabis products to German pharmacies, and WaldhausKlinik Deuringen gGmbH ("Waldhausklinik"), a non-profit acute care hospital for internal medicine in the Free State of Bavaria, announce they have entered into a research collaboration to access the efficacy and safety of medical cannabis.
Sep 13, 2021 03:05 am ET
AMP Alternative Medical Products and Waldhausklinik Deuringen Announce Clinical Study into the Effects of Medical Cannabis
ERFURT, Germany and BERLIN and STADTBERGEN, Germany, Sept. 13, 2021 /CNW/ - AMP Alternative Medical Products Inc. (Frankfurt: C4TA) (ISIN: CA0318961038) (CSE: XCX), a pharmaceutical supplier of medical cannabis products to German pharmacies, and WaldhausKlinik Deuringen gGmbH ("Waldhausklinik"), a non-profit acute care hospital for internal medicine in the Free State of Bavaria, announce they have entered into a research collaboration to access the efficacy and safety of medical cannabis.
Sep 08, 2021 09:00 am ET
/R E P E A T -- AMP Launches its CBD Brand, CANAVEX® at YES!CON, Germany's Largest Cancer Convention/
ERFURT, Germany and BERLIN, Sept. 8, 2021 /CNW/ - AMP Alternative Medical Products Inc. (Frankfurt: C4TA), ISIN: CA0318961038 (CSE: XCX), a pharmaceutical supplier of cosmetic CBD cannabis products to German pharmacies, announces the launch of its newly developed CBD brand, CANAVEX®, sold in German pharmacies without a doctor's prescription, which are distributed thru AMP Alternative Medical Products GmbH.
Sep 08, 2021 03:05 am ET
AMP Launches its CBD Brand, CANAVEX® at YES!CON, Germany's Largest Cancer Convention
ERFURT, Germany and BERLIN, Sept. 8, 2021 /CNW/ - AMP Alternative Medical Products Inc. (Frankfurt: C4TA), ISIN: CA0318961038 (CSE: XCX), a pharmaceutical supplier of cosmetic CBD cannabis products to German pharmacies, announces the launch of its newly developed CBD brand, CANAVEX®, sold in German pharmacies without a doctor's prescription, which are distributed thru AMP Alternative Medical Products GmbH.
Jul 07, 2021 09:00 am ET
/R E P E A T -- AMP Alternative Medical Products: President's Half-Year Letter to Shareholders/
ERFURT, Germany and BERLIN, July 7, 2021 /CNW/ - AMP Alternative Medical Products Inc. (Frankfurt: C4TA) (ISIN: CA0318961038) (CSE: XCX) ("AMP" or "the Company"), a pharmaceutical supplier of medical and CBD wellness cannabis products to the German market, announces the release of its half-year letter to shareholders at: https://amp-eu.com/an-unsere-aktionaere/
Jul 07, 2021 03:06 am ET
AMP Alternative Medical Products: President's Half-Year Letter to Shareholders
ERFURT, Germany and BERLIN, July 7, 2021 /CNW/ - AMP Alternative Medical Products Inc. (Frankfurt: C4TA) (ISIN: CA0318961038) (CSE: XCX) ("AMP" or "the Company"), a pharmaceutical supplier of medical and CBD wellness cannabis products to the German market, announces the release of its half-year letter to shareholders at: https://amp-eu.com/an-unsere-aktionaere/
May 12, 2021 09:00 am ET
/R E P E A T -- AMP Launches HANAFSAN Branded CBD Cannabis Cosmetics Products in Germany/
ERFURT, Germany and BERLIN and VORARLBERG, Austria, May 12, 2021 /CNW/ - AMP Alternative Medical Products Inc. (Frankfurt: C4TA) (ISIN: CA0318961038) (CSE: XCX), a pharmaceutical supplier of medical cannabis products to German pharmacies and Dr. Feurstein Medical Hemp GmbH ("HANAFSAN"), an Austrian pharmaceutical CBD hemp producer have entered into a supply agreement to import and sell HANAFSAN branded certified CBD Hemp cosmetics in Germany.
May 12, 2021 03:05 am ET
AMP Launches HANAFSAN Branded CBD Cannabis Cosmetics Products in Germany
ERFURT, Germany and BERLIN and VORARLBERG, Austria, May 12, 2021 /CNW/ - AMP Alternative Medical Products Inc. (Frankfurt: C4TA) (ISIN: CA0318961038) (CSE: XCX), a pharmaceutical supplier of medical cannabis products to German pharmacies and Dr. Feurstein Medical Hemp GmbH ("HANAFSAN"), an Austrian pharmaceutical CBD hemp producer have entered into a supply agreement to import and sell HANAFSAN branded certified CBD Hemp cosmetics in Germany.
Apr 07, 2021 09:05 am ET
/R E P E A T -- AMP Appoints National Sales Director and Launches Nationwide Marketing Sales Campaign for Branded Medical Cannabis Products in Germany/
ERFURT and BERLIN, Germany, April 7, 2021 /CNW/ - AMP Alternative Medical Products Inc. (Frankfurt: C4TA) (ISIN: CA0318961038) (CSE: XCX), a pharmaceutical supplier of medical cannabis to German pharmacies, announces the appointment of Mr. Robert Schenk as National Sales Director and the launch of AMP's nationwide Marketing Sales Campaign for branded medical cannabis products.
Apr 07, 2021 03:05 am ET
AMP Appoints National Sales Director and Launches Nationwide Marketing Sales Campaign for Branded Medical Cannabis Products in Germany
ERFURT and BERLIN, Germany, April 7, 2021 /CNW/ - AMP Alternative Medical Products Inc. (Frankfurt: C4TA) (ISIN: CA0318961038) (CSE: XCX), a pharmaceutical supplier of medical cannabis to German pharmacies, announces the appointment of Mr. Robert Schenk as National Sales Director and the launch of AMP's nationwide Marketing Sales Campaign for branded medical cannabis products.
Jan 26, 2021 08:00 am ET
/R E P E A T -- AMP German Cannabis Group and Aphria's subsidiary CC Pharma GmbH enter into Strategic Co-Promotion Agreement for the Sale of Medical Cannabis in Germany/
ERFURT/BERLIN/DENSBORN, Germany, and LEAMINGTON, ON, Canada, Jan. 26, 2021 /CNW/ - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX), (Frankfurt: C4T) (ISIN: CA00176G1028) and Aphria Inc.'s ("Aphria") (TSX: APHA) (NASDAQ: APHA) wholly-owned German subsidiary, CC Pharma GmbH ("CC Pharma"), have entered into a strategic agreement (the "Co-Promotion Agreement") covering joint marketing of sales for Aphria brand medical cannabis products for the German market.
Jan 26, 2021 02:05 am ET
AMP German Cannabis Group and Aphria's subsidiary CC Pharma GmbH enter into Strategic Co-Promotion Agreement for the Sale of Medical Cannabis in Germany
ERFURT/BERLIN/DENSBORN, Germany, and LEAMINGTON, ON, Canada, Jan. 26, 2021 /CNW/ - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX), (Frankfurt: C4T) (ISIN: CA00176G1028) and Aphria Inc.'s ("Aphria") (TSX: APHA) (NASDAQ: APHA) wholly-owned German subsidiary, CC Pharma GmbH ("CC Pharma"), have entered into a strategic agreement (the "Co-Promotion Agreement") covering joint marketing of sales for Aphria brand medical cannabis products for the German market.
Dec 16, 2020 02:05 am ET
AMP German Cannabis Group Provides Year-end Letter to Shareholders
ERFURT, Germany and BERLIN, Dec. 16, 2020 /CNW/ - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX) (Frankfurt: C4T) (ISIN: CA00176G1028) is pleased to provide a letter to its shareholders.
Nov 30, 2020 02:00 am ET
AMP Presents Round Table Discussion on Medical Cannabis in the Focus of German Politics with Dr. Wieland Schinnenburg, MdB (FDP)
ERFURT, Germany and BERLIN, Nov. 30, 2020 /CNW/ - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX) (FSE: C4T) (ISIN: CA00176G1028) is proud to present the second episode of its "Round Table" series with Dr. Wieland Schinnenburg, MdB of the FDP, who provides an up-to-date overview of the political issues and challenges facing the medical cannabis in Germany. In addition, the discussion panel will share their views on how the industry will change for companies operating in the sector over the next decade.
Nov 05, 2020 08:05 am ET
/R E P E A T -- AMP German Cannabis Group enters into long term supply agreement with Danish medical cannabis producer Schroll Medical/
ERFURT, Germany and BERLIN and ÅRSLEV, Denmark, Nov. 5, 2020 /CNW/ - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX), (Frankfurt: C4T) (ISIN: CA00176G1028), providing German patients with a wide range of pharmaceutical grade medical cannabis products and Schroll Medical ApS ("Schroll"), a Danish cultivator of medical cannabis, announce that they have entered into a non-exclusive, three-year supply agreement for bulk and packaged EU-GMP cannabis flower which shall be branded under the AMP medical cannabis brand when offered in the German market.
Nov 05, 2020 02:05 am ET
AMP German Cannabis Group enters into long term supply agreement with Danish medical cannabis producer Schroll Medical
ERFURT, Germany and BERLIN and ÅRSLEV, Denmark, Nov. 5, 2020 /CNW/ - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX), (Frankfurt: C4T) (ISIN: CA00176G1028), providing German patients with a wide range of pharmaceutical grade medical cannabis products and Schroll Medical ApS ("Schroll"), a Danish cultivator of medical cannabis, announce that they have entered into a non-exclusive, three-year supply agreement for bulk and packaged EU-GMP cannabis flower which shall be branded under the AMP medical cannabis brand when offered in the German market.
Oct 22, 2020 09:05 am ET
/R E P E A T -- AMP German Cannabis Group adds Little Green Pharma medical cannabis extracts from Australia to its sales offering/
ERFURT / BERLIN, Germany, and PERTH, Western Australia, Oct. 22, 2020 /CNW/ - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX), (Frankfurt: C4T) (ISIN: CA00176G1028), providing German patients with a wide range of pharmaceutical grade medical cannabis products, is pleased to announce it will be adding Little Green Pharma Ltd. (ASX: LGP) cannabis oil medicines to its catalogue for sale in Germany beginning in November 2020 subject to obtaining a BtM-registration (narcotic drug licence) of these products on behalf of AMP.
Oct 22, 2020 03:00 am ET
AMP German Cannabis Group adds Little Green Pharma medical cannabis extracts from Australia to its sales offering
ERFURT / BERLIN, Germany, and PERTH, Western Australia, Oct. 22, 2020 /CNW/ - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX), (Frankfurt: C4T) (ISIN: CA00176G1028), providing German patients with a wide range of pharmaceutical grade medical cannabis products, is pleased to announce it will be adding Little Green Pharma Ltd. (ASX: LGP) cannabis oil medicines to its catalogue for sale in Germany beginning in November 2020 subject to obtaining a BtM-registration (narcotic drug licence) of these products on behalf of AMP.
Sep 15, 2020 09:05 am ET
/R E P E A T -- AMP German Cannabis Group Hires Experienced Sales Director from Canopy Growth/
ERFURT and BERLIN, Germany, Sept. 15, 2020 /CNW/ - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX) (FSE: C4T) (ISIN: CA00176G1028), a licenced importer of medical cannabis into Germany, is pleased to announce the appointment of Mr. Marc Wälken as Sales Director, effective immediately.
Sep 15, 2020 03:05 am ET
AMP German Cannabis Group Hires Experienced Sales Director from Canopy Growth
ERFURT and BERLIN, Germany, Sept. 15, 2020 /CNW/ - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX) (FSE: C4T) (ISIN: CA00176G1028), a licenced importer of medical cannabis into Germany, is pleased to announce the appointment of Mr. Marc Wälken as Sales Director, effective immediately.
Sep 10, 2020 09:05 am ET
/R E P E A T -- AMP German Cannabis Group provides growth strategy update/
ERFURT and BERLIN, Germany, Sept. 10, 2020 /CNW/ - AMP German Cannabis Group Inc. ("AMP" or the "Company") (CSE: XCX) (FSE: C4T) (ISIN: CA00176G1028), a licenced importer of medical cannabis into Germany, provides a strategy update on how it plans to supply Germany with EU-GMP medical cannabis products continuously.
Sep 10, 2020 03:05 am ET
AMP German Cannabis Group provides growth strategy update
ERFURT and BERLIN, Germany, Sept. 10, 2020 /CNW/ - AMP German Cannabis Group Inc. ("AMP" or the "Company") (CSE: XCX) (FSE: C4T) (ISIN: CA00176G1028), a licenced importer of medical cannabis into Germany, provides a strategy update on how it plans to supply Germany with EU-GMP medical cannabis products continuously.
Aug 11, 2020 09:00 am ET
/R E P E A T -- AMP German Cannabis Group enters into Supply Agreement with Canadian Medical cannabis producer, Eve & Co/
ERFURT and BERLIN, Germany and TORONTO, Aug. 11, 2020 /CNW/ - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX) (FSE: C4T) (ISIN: CA00176G1028) and Eve & Co. Incorporated ("Eve & Co.") (TSXV: EVE) (QTCQX: EEVVF) announce they have entered into a supply agreement for the purchase and export to Germany of European Union Good Manufacturing Practice (EU-GMP) medical cannabis flower. The first large import to Germany from Canada is expected before the end of 2020 with 50 to 100 kilograms and monthly imports of up to 100 kilograms to begin 2021.
Aug 11, 2020 03:00 am ET
AMP German Cannabis Group enters into Supply Agreement with Canadian Medical cannabis producer, Eve & Co
ERFURT and BERLIN, Germany and TORONTO, Aug. 11, 2020 /CNW/ - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX) (FSE: C4T) (ISIN: CA00176G1028) and Eve & Co. Incorporated ("Eve & Co.") (TSXV: EVE) (QTCQX: EEVVF) announce they have entered into a supply agreement for the purchase and export to Germany of European Union Good Manufacturing Practice (EU-GMP) medical cannabis flower. The first large import to Germany from Canada is expected before the end of 2020 with 50 to 100 kilograms and monthly imports of up to 100 kilograms to begin 2021.
Aug 04, 2020 09:00 am ET
/R E P E A T -- AMP German Cannabis Group Presents Roundtable Discussion with European Medical Cannabis Expert, Dr. Franjo Grotenhermen and Dr. Stefan Feuerstein about Medical Cannabis in Germany/
ERFURT and BERLIN, Germany, Aug. 4, 2020 /CNW/ - AMP German Cannabis Group Inc. ("AMP" or the "Company") (CSE: XCX) (FSE: C4T) (ISIN: CA00176G1028) proudly presents its first video in a series of in-depth roundtable discussions that will explore and discuss new developments regarding medical cannabis in Germany. The Roundtable Series online videos are in German with English subtitles.
Aug 04, 2020 03:00 am ET
AMP German Cannabis Group Presents Roundtable Discussion with European Medical Cannabis Expert, Dr. Franjo Grotenhermen and Dr. Stefan Feuerstein about Medical Cannabis in Germany
ERFURT and BERLIN, Germany, Aug. 4, 2020 /CNW/ - AMP German Cannabis Group Inc. ("AMP" or the "Company") (CSE: XCX) (FSE: C4T) (ISIN: CA00176G1028) proudly presents its first video in a series of in-depth roundtable discussions that will explore and discuss new developments regarding medical cannabis in Germany. The Roundtable Series online videos are in German with English subtitles.
Jul 21, 2020 08:00 am ET
/R E P E A T -- AMP German Cannabis Group orders 150 kilograms of medical cannabis from Canadian Licensed Producer/
ERFURT and BERLIN, Germany, July 21, 2020 /CNW/ - AMP German Cannabis Group Inc. ("AMP" or the "Company") (FSE: C4T) (ISIN: CA00176G1028) (CSE: XCX) announces it has placed two orders for bulk and finished EU-GMP medical cannabis flower from a Canadian Licensed Producer ("Canadian LP") of medical cannabis. AMP will be purchasing and importing to Germany, 50 kilograms of EU-GMP medical cannabis in September 2020 and a further 100 kilograms during January/February 2021. AMP and the Canadian LP plan to expand the supply agreement for monthly large volume purchases of medical cannabis as well as
Jul 21, 2020 02:00 am ET
AMP German Cannabis Group orders 150 kilograms of medical cannabis from Canadian Licensed Producer
ERFURT and BERLIN, Germany, July 21, 2020 /CNW/ - AMP German Cannabis Group Inc. ("AMP" or the "Company") (FSE: C4T) (ISIN: CA00176G1028) (CSE: XCX) announces it has placed two orders for bulk and finished EU-GMP medical cannabis flower from a Canadian Licensed Producer ("Canadian LP") of medical cannabis. AMP will be purchasing and importing to Germany, 50 kilograms of EU-GMP medical cannabis in September 2020 and a further 100 kilograms during January/February 2021. AMP and the Canadian LP plan to expand the supply agreement for monthly large volume purchases of medical cannabis as well as
Jul 06, 2020 08:00 am ET
/R E P E A T -- AMP German Cannabis Group to begin medical cannabis imports from the Netherlands/
ERFURT and BERLIN, Germany, July 6, 2020 /CNW/ - AMP German Cannabis Group Inc. ("AMP" or the "Company") (CSE: XCX) (FSE: C4T, ISIN: CA00176G1028) announces further to its June 5, 2020 news release The Office of Medical Cannabis ("OMC"), the government organization of the Netherlands for distribution of medical cannabis products, has notified AMP that it will resume exports of EU-GMP medical cannabis to Germany. The OMC will deliver 3,000 grams per month to each German importer due to the high demand and restricted supply currently available for Germany.
Jul 06, 2020 02:00 am ET
AMP German Cannabis Group to begin medical cannabis imports from the Netherlands
ERFURT and BERLIN, Germany, July 6, 2020 /CNW/ - AMP German Cannabis Group Inc. ("AMP" or the "Company") (CSE: XCX) (FSE: C4T, ISIN: CA00176G1028) announces further to its June 5, 2020 news release The Office of Medical Cannabis ("OMC"), the government organization of the Netherlands for distribution of medical cannabis products, has notified AMP that it will resume exports of EU-GMP medical cannabis to Germany. The OMC will deliver 3,000 grams per month to each German importer due to the high demand and restricted supply currently available for Germany.
Jun 29, 2020 09:35 am ET
AMP German Cannabis Group announces AGM results and appointment of new CFO
ERFURT and BERLIN, Germany, June 29, 2020 /CNW/ - AMP German Cannabis Group Inc. ("AMP" or the "Company") (FSE: C4T) (ISIN: CA00176G1028) (CSE: XCX) held its annual general meeting of shareholders (AGM) earlier today. The shareholders approved all resolutions put before them, namely:
Jun 08, 2020 08:00 am ET
/R E P E A T -- AMP German Cannabis Group to develop medical cannabis brands for the German market/
AMP is fully licenced to import medical cannabis from Europe and other countries Building brands for the German medical cannabis market supplied by foreign licenced producers Large volume Canadian imports projected to begin in the fall of 2020 under AMP brand ERFURT, Germany and BERLIN, June 8, 2020 /CNW/ - AMP German Cannabis Group Inc. ("AMP" or the "Company") (CSE: XCX) (FSE: C4T) (ISIN: CA00176G1028) announces it is developing medical brands for a range of cannabis flower strains, extracts and other novel dosage forms specifically for the German market supplied by foreign licenced medic
Jun 08, 2020 02:00 am ET
AMP German Cannabis Group to develop medical cannabis brands for the German market
AMP is fully licenced to import medical cannabis from Europe and other countries Building brands for the German medical cannabis market supplied by foreign licenced producers Large volume Canadian imports projected to begin in the fall of 2020 under AMP brand ERFURT, Germany and BERLIN, June 8, 2020 /CNW/ - AMP German Cannabis Group Inc. ("AMP" or the "Company") (CSE: XCX) (FSE: C4T) (ISIN: CA00176G1028) announces it is developing medical brands for a range of cannabis flower strains, extracts and other novel dosage forms specifically for the German market supplied by foreign licenced medic
Jun 02, 2020 08:00 am ET
/R E P E A T -- AMP German Cannabis Group sets date for Annual General Meeting and Online Question & Answer Session/
ERFURT, Germany and BERLIN, June 2, 2020 /CNW/ - AMP German Cannabis Group Inc. ("AMP" or the "Company") (CSE: XCX) (FSE: C4T, ISIN: CA00176G1028) will hold its Annual General Meeting of Shareholders (AGM) on Monday, June 29th, 2020, beginning at 3:00 p.m. Central European Time (6:00 a.m. Pacific Standard Time) to conduct formal business follow by an online question and answer session with AMP's management.
Jun 02, 2020 02:00 am ET
AMP German Cannabis Group sets date for Annual General Meeting and Online Question & Answer Session
ERFURT, Germany and BERLIN, June 2, 2020 /CNW/ - AMP German Cannabis Group Inc. ("AMP" or the "Company") (CSE: XCX) (FSE: C4T, ISIN: CA00176G1028) will hold its Annual General Meeting of Shareholders (AGM) on Monday, June 29th, 2020, beginning at 3:00 p.m. Central European Time (6:00 a.m. Pacific Standard Time) to conduct formal business follow by an online question and answer session with AMP's management.
Apr 14, 2020 08:00 am ET
/R E P E A T -- AMP German Cannabis Group Receives Irradiation Licence for Medical Cannabis Imports into Germany/
BERLIN, April 14, 2020 /CNW/ - AMP German Cannabis Group Inc. ("AMP" or the "Company") (CSE: XCX) (FSE: C4T, ISIN: CA00176G1028) is pleased to announce it has successfully obtained all the required licences to import, store at its licensed narcotic storage facility and distribute to its pharmaceutical distributors irradiated EU-GMP certified medical cannabis flower.
Apr 14, 2020 03:00 am ET
AMP German Cannabis Group Receives Irradiation Licence for Medical Cannabis Imports into Germany
BERLIN, April 14, 2020 /CNW/ - AMP German Cannabis Group Inc. ("AMP" or the "Company") (CSE: XCX) (FSE: C4T, ISIN: CA00176G1028) is pleased to announce it has successfully obtained all the required licences to import, store at its licensed narcotic storage facility and distribute to its pharmaceutical distributors irradiated EU-GMP certified medical cannabis flower.
Mar 09, 2020 08:00 am ET
/R E P E A T -- AMP German Cannabis Group Receives Import Licence for Medical Cannabis for Imports from European Union Countries/
BERLIN, March 9, 2020 /CNW/ - AMP German Cannabis Group Inc. ("AMP" or the "Company") (CSE: XCX) (FSE: C4T, ISIN: CA00176G1028) announces that the Thuringian State Office for Consumer Protection or Thüringer Landesamt für Verbraucherschutz, ("TLV") has granted an additional import licence for cannabis products for medical purposes from European countries to Germany in accordance to Paragraph §52a of the German Medicine Law or Arzneimittelgesetz to Alternative Medical Products GmbH ("AMP Germany"), a wholly-owned subsidiary of AMP.
Mar 09, 2020 03:00 am ET
AMP German Cannabis Group Receives Import Licence for Medical Cannabis for Imports from European Union Countries
BERLIN, March 9, 2020 /CNW/ - AMP German Cannabis Group Inc. ("AMP" or the "Company") (CSE: XCX) (FSE: C4T, ISIN: CA00176G1028) announces that the Thuringian State Office for Consumer Protection or Thüringer Landesamt für Verbraucherschutz, ("TLV") has granted an additional import licence for cannabis products for medical purposes from European countries to Germany in accordance to Paragraph §52a of the German Medicine Law or Arzneimittelgesetz to Alternative Medical Products GmbH ("AMP Germany"), a wholly-owned subsidiary of AMP.
Jan 15, 2020 07:00 am ET
/R E P E A T -- AMP German Cannabis Group Provides Corporate Update/
BERLIN, Jan. 15, 2020 /CNW/ - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX), (Frankfurt: C4T, ISIN: CA00176G1028) provides an update on its strategy to become one of the leading importers of European Union - Good Manufacturing Practices (EU-GMP) medical cannabis into Germany through its network of suppliers from Canada, Europe and other non-European countries.
Jan 15, 2020 01:00 am ET
AMP German Cannabis Group Provides Corporate Update
BERLIN, Jan. 15, 2020 /CNW/ - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX), (Frankfurt: C4T, ISIN: CA00176G1028) provides an update on its strategy to become one of the leading importers of European Union - Good Manufacturing Practices (EU-GMP) medical cannabis into Germany through its network of suppliers from Canada, Europe and other non-European countries.
Nov 18, 2019 07:00 am ET
/R E P E A T -- AMP German Cannabis Group Receives an Import Licence for Medical Cannabis from the German State of Thuringia/
BERLIN and ERFURT, Germany, Nov. 18, 2019 /CNW/ - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX), (Frankfurt: C4T, ISIN: CA00176G1028) announces the Thuringian State Office for Consumer Protection (Thueringer Landesamt fuer Verbraucherschutz) ("TLV") has granted an import licence for cannabis products for medical purposes for Germany according to Section 72 of the German Medicine Law (Arzneimittelgesetz - AMG) to Alternative Medical Products GmbH ("AMP Germany"), a wholly-owned subsidiary of AMP.
Nov 18, 2019 01:00 am ET
AMP German Cannabis Group Receives an Import Licence for Medical Cannabis from the German State of Thuringia
BERLIN and ERFURT, Germany, Nov. 18, 2019 /CNW/ - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX), (Frankfurt: C4T, ISIN: CA00176G1028) announces the Thuringian State Office for Consumer Protection (Thueringer Landesamt fuer Verbraucherschutz) ("TLV") has granted an import licence for cannabis products for medical purposes for Germany according to Section 72 of the German Medicine Law (Arzneimittelgesetz - AMG) to Alternative Medical Products GmbH ("AMP Germany"), a wholly-owned subsidiary of AMP.
Oct 16, 2019 08:00 am ET
/R E P E A T -- AMP German Cannabis Group Signs Distribution Agreement with CC Pharma, a Wholly Owned Subsidiary of Aphria and a Leading Pharmaceutical and Medical Cannabis Distributer in Germany/
AMP to supply the growing Germany market with pharmaceutical medical cannabis imported from Canada
Oct 15, 2019 05:07 pm ET
IIROC Trade Resumption - XCX
VANCOUVER, Oct. 15, 2019 /CNW/ - Trading resumes in:
Oct 15, 2019 04:53 pm ET
AMP German Cannabis Group Signs Distribution Agreement with CC Pharma, a Wholly Owned Subsidiary of Aphria and a Leading Pharmaceutical and Medical Cannabis Distributer in Germany
AMP to supply the growing Germany market with pharmaceutical medical cannabis imported from Canada
Oct 15, 2019 12:45 pm ET
IIROC Trading Halt - XCX
VANCOUVER, Oct. 15, 2019 /CNW/ - The following issues have been halted by IIROC:
Oct 10, 2019 08:00 am ET
/R E P E A T -- AMP German Cannabis Group begins EU-GMP audit of its medical cannabis supply chain in Germany/
BERLIN, Oct. 10, 2019 /CNW/ - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX), (Frankfurt: C4T, ISIN: CA00176G1028) announces that it has begun conducting an European Union (EU) Good Manufacturing Procedure (EU-GMP) audit of its supply chain logistics in Germany to ensure that the quality and integrity of pharmaceutical goods during transportation and storage is maintained throughout the supply chain from the supplier to the German patient.
Oct 10, 2019 02:00 am ET
AMP German Cannabis Group begins EU-GMP audit of its medical cannabis supply chain in Germany
BERLIN, Oct. 10, 2019 /CNW/ - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX), (Frankfurt: C4T, ISIN: CA00176G1028) announces that it has begun conducting an European Union (EU) Good Manufacturing Procedure (EU-GMP) audit of its supply chain logistics in Germany to ensure that the quality and integrity of pharmaceutical goods during transportation and storage is maintained throughout the supply chain from the supplier to the German patient.
Oct 08, 2019 08:00 am ET
/R E P E A T -- AMP German Cannabis Group Enters into memorandum of understanding supply agreement for the import of EU-GMP medical cannabis into Germany/
BERLIN, Oct. 8, 2019 /CNW/ - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX), (Frankfurt: C4T, ISIN: CA00176G1028) announces that it has entered into a non-binding memorandum of understanding to purchase up to 1,200 kilograms of either branded or white-labeled European Union - Good Manufacturing Practice (EU-GMP) medical cannabis flower annually from an Alberta based supplier with a cultivation and processing licence from Health Canada ("Alberta LP").
Oct 08, 2019 02:00 am ET
AMP German Cannabis Group Enters into memorandum of understanding supply agreement for the import of EU-GMP medical cannabis into Germany
BERLIN, Oct. 8, 2019 /CNW/ - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX), (Frankfurt: C4T, ISIN: CA00176G1028) announces that it has entered into a non-binding memorandum of understanding to purchase up to 1,200 kilograms of either branded or white-labeled European Union - Good Manufacturing Practice (EU-GMP) medical cannabis flower annually from an Alberta based supplier with a cultivation and processing licence from Health Canada ("Alberta LP").
Sep 17, 2019 08:00 am ET
AMP German Cannabis Group Supplier, Pure Life Cannabis, Completes EU-GMP Gap Analysis
BERLIN, Sept. 17, 2019 /CNW/ - AMP German Cannabis Group Inc. ("AMP") (CSE: XCX), (Frankfurt: C4T, ISIN: CA00176G1028) announces that one of its prospective medical cannabis supplier, Pure Life Cannabis Corp. ("Pure Life"), has completed its European Union Good Manufacturing Practice ("EU-GMP") gap analysis and will undergo an EU-GMP audit before calendar year-end. Upon passing the EU-GMP audit, Pure Life will be subject to an EU-GMP inspection and certification by German State officials.
Sep 06, 2019 08:00 am ET
/R E P E A T -- AMP German Cannabis Group Announces Stock Option Grant/
BERLIN, Sept. 6, 2019 /CNW/ - AMP German Cannabis Group Inc. ("AMP" or the "Company") (CSE: XCX), (FSE: C4T, ISIN: CA00176G1028) announces that it has granted incentive stock options to purchase up to 2,123,779 common shares of the Company to certain directors, officers, employees and consultants in accordance with its stock option plan, including options to purchase up to 1,175,000 shares to certain directors and officers. Each option vests immediately has an exercise price of $0.50 per share and is exercisable for a period of one year from issuance.
Sep 06, 2019 02:00 am ET
AMP German Cannabis Group Announces Stock Option Grant
BERLIN, Sept. 6, 2019 /CNW/ - AMP German Cannabis Group Inc. ("AMP" or the "Company") (CSE: XCX), (FSE: C4T, ISIN: CA00176G1028) announces that it has granted incentive stock options to purchase up to 2,123,779 common shares of the Company to certain directors, officers, employees and consultants in accordance with its stock option plan, including options to purchase up to 1,175,000 shares to certain directors and officers. Each option vests immediately has an exercise price of $0.50 per share and is exercisable for a period of one year from issuance.
Sep 05, 2019 09:00 am ET
CSE New Listing - AMP German Cannabis Group Commences Trading on the Canadian Securities Exchange - Video News Alert on Investmentpitch.com
Vancouver, British Columbia--(Newsfile Corp. - September 5, 2019) - AMP German Cannabis Group (CSE: XCX) (FSE: C4T) is one of the latest new listings on the Canadian Securities Exchange, having previously traded on the TSX Venture Exchange as Chinook Tyee Industry Ltd. Based in Erfurt, Germany, AMP invests, through its subsidiaries, in businesses that supply the German medical cannabis industry.
Sep 04, 2019 08:00 am ET
/R E P E A T -- AMP German Cannabis Group Commence Trading on the CSE and Announces Investment Policy Focused on the European Medical Cannabis Industry/
New investments will focus on supplying Germany with medical cannabis AMP's lead investment, AMP Germany, plans to become a significant importer of medical cannabis to Germany from Canada AMP Switzerland plans to invest in the Swiss cannabis market BERLIN, Sept. 4, 2019 /CNW/ - AMP German Cannabis Group Inc. ("AMP" or the "Company") (formerly "Chinook Tyee Industry Limited") (CSE: XCX), (FSE: C4T), (ISIN: CA00176G1028) announces the commencement of trading of its common shares on the Canadian Securities Exchange (CSE). The Company's common shares were delisted from the TSX Venture Exchang
Sep 04, 2019 02:00 am ET
AMP German Cannabis Group Commence Trading on the CSE and Announces Investment Policy Focused on the European Medical Cannabis Industry
New investments will focus on supplying Germany with medical cannabis AMP's lead investment, AMP Germany, plans to become a significant importer of medical cannabis to Germany from Canada AMP Switzerland plans to invest in the Swiss cannabis market BERLIN, Sept. 4, 2019 /CNW/ - AMP German Cannabis Group Inc. ("AMP" or the "Company") (formerly "Chinook Tyee Industry Limited") (CSE: XCX), (FSE: C4T), (ISIN: CA00176G1028) announces the commencement of trading of its common shares on the Canadian Securities Exchange (CSE). The Company's common shares were delisted from the TSX Venture Exchang
Aug 23, 2019 12:01 am ET
/R E P E A T -- Chinook Announces Name Change to AMP German Cannabis Group and Listing on the Canadian Securities Exchange/
BERLIN, Aug. 22, 2019 /CNW/ - Chinook Tyee Industry Limited ("Chinook" or the "Company") (TSXV: XCX), (Frankfurt: C4T: ISIN: CA16961T2083) announces that the Canadian Securities Exchange ("CSE") has approved the listing of the Company's Class A Voting Common Shares Without Par Value ("Common Shares") and will begin trading at market open on September 4, 2019 under the Company's current symbol, "XCX" ("CSE Listing"). The Company also announces that it has changed its name to "AMP German Cannabis Group Inc." and its new CUSIP number will be 00176G102 and its ISIN will be CA00176G1028.
Aug 22, 2019 08:22 pm ET
Chinook Announces Name Change to AMP German Cannabis Group and Listing on the Canadian Securities Exchange
BERLIN, Aug. 22, 2019 /CNW/ - Chinook Tyee Industry Limited ("Chinook" or the "Company") (TSXV: XCX), (Frankfurt: C4T: ISIN: CA16961T2083) announces that the Canadian Securities Exchange ("CSE") has approved the listing of the Company's Class A Voting Common Shares Without Par Value ("Common Shares") and will begin trading at market open on September 4, 2019 under the Company's current symbol, "XCX" ("CSE Listing"). The Company also announces that it has changed its name to "AMP German Cannabis Group Inc." and its new CUSIP number will be 00176G102 and its ISIN will be CA00176G1028.
Jun 12, 2019 09:00 am ET
/R E P E A T -- Chinook Closes $1.5 Million Canadian Dollar Series A Private Placement/
Chinook Insiders are the largest investors in the Series A financing as its German subsidiary expands in the European medical cannabis industry
Jun 12, 2019 03:00 am ET
Chinook Closes $1.5 Million Canadian Dollar Series A Private Placement
Chinook Insiders are the largest investors in the Series A financing as its German subsidiary expands in the European medical cannabis industry
May 29, 2019 09:00 am ET
Chinook joins forces with a leading German pharmaceutical consulting company
Chinook establishes EU-GMP standards for its imports of medical cannabis to Germany from Canada
Feb 07, 2019 08:00 am ET
Chinook's subsidiary, AMP Alternative Medical Products, enters into a memorandum of understanding with Pure Life Cannabis for export to Germany
ERFURT, Germany and EDMONTON, Feb. 7, 2019 /CNW/ - AMP Alternative Medical Products GmbH ("AMP"), a subsidiary of Chinook Tyee Industry Limited ("Chinook") (TSXV: XCX), has entered into a non-binding Memorandum of Understanding Production Supply Agreement ("MOU") with Pure Life Cannabis Corporation ("PLCC"), a late-stage Health Canada applicant to become a licensed producer of cannabis ("LP") based in Edmonton, Alberta.
Feb 05, 2019 08:00 am ET
Update on Chinook's Investments in Germany
BERLIN, Feb. 5, 2019 /PRNewswire/ - Chinook Tyee Industry Limited ("Chinook") (TSXV: XCX) is an investment finance company with two European subsidiaries, AMP Alternative Medical Products GmbH based in Erfurt, Germany and Mercury Partners & Company plc based in Valletta, Malta. Chinook has 10,217,796 fully diluted shares issued and outstanding and net investment assets of over $2.0 million (unaudited) as of September 30th, 2018.
Feb 05, 2019 08:00 am ET
Update on Chinook's Investments in Germany
BERLIN, Feb. 5, 2019 /CNW/ - Chinook Tyee Industry Limited ("Chinook") (TSXV: XCX) is an investment finance company with two European subsidiaries, AMP Alternative Medical Products GmbH based in Erfurt, Germany and Mercury Partners & Company plc based in Valletta, Malta. Chinook has 10,217,796 fully diluted shares issued and outstanding and net investment assets of over $2.0 million (unaudited) as of September 30th, 2018.
Dec 03, 2018 06:00 am ET
Chinook subsidiary, AMP Alternative Medical Products, receives €500,000 Series B financing to fund its medical cannabis business in Germany
ERFURT, Germany, Dec. 3, 2018 /PRNewswire/ - Chinook Tyee Industry Limited ("Chinook") (TSXV: XCX) announces that AMP Alternative Medical Products GmbH ("AMP"), its wholly-owned subsidiary, has entered into a €500,000 Series B drawdown loan facility provided by Taiga Atlas plc ("Taiga Atlas"). AMP completed a €75,000 Series A equity financing with Chinook during 2018.
Dec 03, 2018 06:00 am ET
Chinook subsidiary, AMP Alternative Medical Products, receives €500,000 Series B financing to fund its medical cannabis business in Germany
ERFURT, Germany, Dec. 3, 2018 /CNW/ - Chinook Tyee Industry Limited ("Chinook") (TSXV: XCX) announces that AMP Alternative Medical Products GmbH ("AMP"), its wholly-owned subsidiary, has entered into a €500,000 Series B drawdown loan facility provided by Taiga Atlas plc ("Taiga Atlas"). AMP completed a €75,000 Series A equity financing with Chinook during 2018.
Sep 26, 2016 06:00 am ET
Direct Sales Children Apparel Retailer, Peekaboo Beans Inc. Completes Reverse Takeover
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS.Peekaboo Beans Inc., formerly North Group Finance Limited...
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Canadianinsider.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Read more...Insider information is based on filings made on the System
for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission.Read less
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Interactive technical study charts by TradingView. Copyright © 2024 INK Research Corp. All rights reserved. All trade-marks or trade names not owned by INK Research Corp. are the property of their respective owners.
